Kojiro Shimozuma
- Oncology top 2%
- Cancer Treatment and Pharmacology 36
- Cancer survivorship and care 24
- HER2/EGFR in Cancer Research 11
- Dermatology top 2%
- Chemotherapy-related skin toxicity 11
- Cancer Research top 5%
- Breast Cancer Treatment Studies 25
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life 34
- Economic and Financial Impacts of Cancer 9
- Geriatrics and Gerontology top 5%
-
- Cancer-related cognitive impairment studies 11
- Co-authors
- Takeru ShiroiwaTakashi FukudaShinya SaitoKatsumasa KuroiShozo OhsumiYasuo OhashiShunya IkedaShinichi Noto
- Cited by
- OncologyDermatologyCancer Research
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Kojiro Shimozuma
140 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 133
- Oncology 1.4k
- Dermatology 270
- Cancer Research 450
- Economics and Econometrics 493
- Geriatrics and Gerontology 70
Countries citing papers authored by Kojiro Shimozuma
This map shows the geographic impact of Kojiro Shimozuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kojiro Shimozuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kojiro Shimozuma more than expected).
Fields of papers citing papers by Kojiro Shimozuma
This network shows the impact of papers produced by Kojiro Shimozuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kojiro Shimozuma. The network helps show where Kojiro Shimozuma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kojiro Shimozuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 32 | |
| 9 | 2016 | 212 | |
| 10 | 2016 | 9 | |
| 11 | Developing a Japanese version of the EQ-5D-5L value set | 2015 | 127 |
| 12 | Guideline for economic evaluation of healthcare technologies in Japan | 2013 | 46 |
| 13 | 2013 | 35 | |
| 14 | 2012 | 0 | |
| 15 | 2012 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2011 | 54 | |
| 18 | 2011 | 15 | |
| 19 | 2011 | 10 | |
| 20 | 2006 | 114 |
About Kojiro Shimozuma
Kojiro Shimozuma is a scholar working on Oncology, Cancer Research and Geriatrics and Gerontology, having authored 148 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (36 papers), Health Systems, Economic Evaluations, Quality of Life (34 papers), Breast Cancer Treatment Studies (25 papers), Cancer survivorship and care (24 papers), Chemotherapy-related skin toxicity (11 papers), Cancer-related cognitive impairment studies (11 papers), HER2/EGFR in Cancer Research (11 papers) and Economic and Financial Impacts of Cancer (9 papers). The work is most often cited by research in Oncology (1.4k citations), Dermatology (270 citations) and Cancer Research (450 citations). Kojiro Shimozuma has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Takeru Shiroiwa, Takashi Fukuda, Shinya Saito, Katsumasa Kuroi, Shozo Ohsumi, Yasuo Ohashi, Shunya Ikeda, Shinichi Noto, Ataru Igarashi and Hirohisa Imai. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.